Adalimumab 53877-0801-01
- Manufacturer
- Terumo Corporation
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- July 1, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Fkjp | 40 mg/.8mL |
Selected Package
53877-0801-01Selected144 SYRINGE in 1 BOX (53877-801-01) / .8 mL in 1 SYRINGE